You searched for "occlusion"
Glaukos Trabecular Micro-Bypass Surgical Masterclass
7 June 2025
Agenda10:00am - Coffee10:30am - Welcome/Introduction to Glaukos Masterclass (Niven Smith)11:00am- Why trabecular bypass? (Mr Imran Masood)11:30am- iStent W surgical technique (Mr Imran Masood)12:00pm- iStent W as the standard care at the time of cataract - evidence and experience (Miss Nada...
Glaukos: Trabecular Micro-Bypass Surgical Masterclass November
22 November 2025
Agenda 10:00am Coffee10:30am Welcome/Introduction to Glaukos Masterclass - Niven Smith11:00am Why trabecular bypass? - Mr Imran Masood, Birmingham11:30am iStent inject W surgical technique - Mr Imran Masood, Birmingham12:00pm iStent inject W as the standard care at te time of cataract...
What not to miss in neuro-ophthalmology Part 2
1 August 2018
|
EYE - Neuro-ophthalmology
As mentioned previously there are several conditions in neuro-ophthalmology that should not be missed by the general ophthalmologist as well as ophthalmology trainees. We discussed in the first part some of these conditions including third cranial nerve palsies, giant cell...
Making sense of the orthoptic assessment
1 April 2020
| Joe Smith
|
EYE - Cataract
Following the Specialty Trainee article on this topic in the February/March 2020 issue, Joe Smith provides a more detailed breakdown of the orthoptic report. Orthoptists investigate, diagnose and manage a wide variety of patients with varying problems. In this article,...
Direct endoscopic probing for congenital lacrimal duct obstruction
1 April 2014
| Anjali Gupta
|
EYE - General
The most common treatment for congenital lacrimal duct obstruction (CLDO) is probing, which is traditionally a blind procedure. Previous literature reports success rates between 78-92%. The authors of this retrospective non comparative case series reviewed the success rates of probing...
Intravitreal injections delivered by ophthalmic clinical nurse specialists
1 June 2015
| Rita McLauchlan, D Armstrong, Konstantinos Balaskas, Sajjad Mahmood
|
EYE - Vitreo-Retinal
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...
Minister for equalities backs Sight Scotland’s push to break down accessibility barriers in Scottish venues
Equalities Minister Kaukab Stewart recently met with Sight Scotland’s Policy Group to discuss the importance of improving access and inclusion in Scotland’s venues. She stressed that everyone should have the freedom to enjoy life and visit places of their choice,...Technology in ophthalmology – a promising future and what we need to know about the regulations
1 October 2017
| Priya Nidamanuri, Magdalena Popiela
|
EYE - Cataract, EYE - Refractive, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Orbit, EYE - Vitreo-Retinal, EYE - General
Undoubtedly, ophthalmology is one of the greatest sources of inspiration for technological progress in medicine. Thus far, we have seen remarkable advancements in the technology used by ophthalmologists across all subspecialties. From simplifying common procedures, to treating previously incurable conditions,...
Toxoplasmosis and the associated retinochoroiditis: important facts and when to treat
1 April 2017
| Annie SeeWah Tung
|
EYE - Vitreo-Retinal
Annie SeeWah Tung provides an overview of toxoplasmosis retinochoroiditis, including guidance on which cases should be treated and the treatment options. Toxoplasmosis retinochoroiditis is an infectious condition that is characterised by retinochoroidal lesions commonly in the posterior pole and is...
Post-stroke visual impairment: how big is the problem, how do we identify it, what we can do about it, and why does it matter?
1 December 2022
| Lauren R Hepworth
|
EYE - General
In the UK, 100,000 new strokes occur each year, with 1.3 million stroke survivors [1]. This article will focus on post-stroke visual impairment, discussing topics of how common it is, how it can be detected, possible management options and how...
Nano-ophthalmology paves a new path in the future of eyecare
1 December 2022
| Stylianos Mastronikolis, Jayasis Bandyopadhyay
|
EYE - General
Introduction The treatments of ocular conditions in the field of ophthalmology varies from topical to surgical procedures. The field of nanotechnology is one of the fast-growing fields of medicine, which plays an important role in turning the impossibilities of the...
